Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease.

Steeland S, Gorlé N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, Van Imschoot G, Van Wonterghem E, De Rycke R, Kremer A, Lippens S, Stopa E, Johanson CE, Libert C, Vandenbroucke RE.

EMBO Mol Med. 2018 Apr;10(4). pii: e8300. doi: 10.15252/emmm.201708300.

2.

The choroid plexus epithelium as a novel player in the stomach-brain axis during Helicobacter infection.

Gorlé N, Blaecher C, Bauwens E, Vandendriessche C, Balusu S, Vandewalle J, Van Cauwenberghe C, Van Wonterghem E, Van Imschoot G, Liu C, Ducatelle R, Libert C, Haesebrouck F, Smet A, Vandenbroucke RE.

Brain Behav Immun. 2018 Mar;69:35-47. doi: 10.1016/j.bbi.2017.12.010. Epub 2017 Dec 16.

PMID:
29258921
3.

The effect of aging on brain barriers and the consequences for Alzheimer's disease development.

Gorlé N, Van Cauwenberghe C, Libert C, Vandenbroucke RE.

Mamm Genome. 2016 Aug;27(7-8):407-20. doi: 10.1007/s00335-016-9637-8. Epub 2016 May 3. Review.

PMID:
27143113
4.

Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.

Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, Van Hove I, Moons L, De Strooper B, Kanazir S, Libert C, Vandenbroucke RE.

J Neurosci. 2015 Sep 16;35(37):12766-78. doi: 10.1523/JNEUROSCI.0006-15.2015.

Supplemental Content

Support Center